Large pharmaceutical groups’ expectations in terms of research and taxes
Source: Actu Labo
From: France

According to Frederic Thomas, Associate Director for Arthur D. Little Paris , French pharmaceutical manufacturers depend too much on mature and generic products. Many French factories are in a very fragile situation. He has recently audited around 50 manufacturing sites and noted that most of them are positioned on mature products.